Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- We may be subject to significant liability should the consumption of our pharmacy products cause injury, illness, or death.
- Our pharmacy business derives substantially all revenue from sales of prescription medications reimbursed by third-party payors, including Medicare Part D plans.
- In April 2024, CMS adopted final rules limiting compensation for certain distributors of Medicare products, impacting our operations.
- Issues related to AI development could lead to legal action, damaging our reputation and materially harming our business.
- We recorded impairment charges of $15.6 million related to our intangible assets during the year ended June 30, 2024.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1794783&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.